How Is a Breast or Armpit Lump Evaluated for Breast Cancer?
At a Glance
A new or changing lump in the upper-outer breast or armpit cannot be reliably identified by touch alone. Doctors use a physical exam, targeted ultrasound and/or diagnostic mammography, then biopsy if imaging is suspicious or does not explain the lump.
Finding a lump in the upper-outer quadrant of your breast or near your armpit can be frightening, but many lumps have noncancerous causes. When you find one, doctors evaluate it through a combination of a clinical physical exam, targeted imaging (like ultrasound and diagnostic mammography), and sometimes a biopsy. Because this area contains breast tissue, lymph nodes, and other structures, a physical exam alone cannot reliably tell exactly what the lump is or whether it is benign (non-cancerous) or malignant [1][2]. Therefore, any new or changing lump requires prompt medical evaluation to visualize the tissue and, if needed, sample it for a definitive diagnosis [1]. Do not wait for your next screening exam; schedule an appointment. If you experience fever, rapidly increasing redness or swelling, or severe pain, seek more urgent medical advice [3].
What Could the Lump Be?
The area where your breast meets your armpit is anatomically complex. A lump in this region might involve:
- The Axillary Tail (Tail of Spence): This is a normal extension of the upper-outer breast parenchyma (the milk-producing tissue) that reaches up into the armpit [4].
- Accessory Breast Tissue: Some people have normal, ectopic breast tissue that developed along the embryologic “mammary ridge” extending into the armpit [4][5]. While cancer in this area is uncommon, this tissue can develop the same benign conditions or cancers as the rest of the breast [4].
- Lymph Nodes: The armpit contains a network of lymph nodes. An enlarged node could indicate a recent infection, skin inflammation, a benign immune response (such as a reaction to a recent vaccine), or cancer [6].
- Other Structures: Lumps can also arise from skin (such as cysts), fat, muscle, or blood vessels in the armpit [6].
Step-by-Step Evaluation
Doctors follow a specific sequence to evaluate a lump in the upper-outer breast or armpit. Recommendations apply to all people with breast tissue, including men and transgender or nonbinary patients [7][8].
1. Clinical Examination
Your doctor will begin by feeling the lump and surrounding tissue to assess its size, firmness, and mobility. However, a benign lump in accessory breast tissue might feel exactly like a swollen lymph node or a cancerous tumor [9][10]. Because of this, clinical examination is only the first step and must be paired with imaging [2][11].
2. Diagnostic Imaging
Depending on your age, symptoms, and exactly where the lump is located, your doctor will order diagnostic imaging—which is more focused than a routine screening [12][13].
- Targeted Ultrasound: Ultrasound uses sound waves to determine whether a lump is solid or filled with fluid (like a simple cyst), and it helps distinguish between an enlarged lymph node, a mass in the breast tissue, or a skin lesion [5][12]. If the lump is isolated strictly to the armpit (axilla), targeted ultrasound is often the key initial test at any age [14]. Ultrasound is also typically the first test for people under 30 or those who are pregnant or lactating [12][15]. (Note: If clinically indicated, diagnostic mammography can still be performed safely during pregnancy [16]).
- Diagnostic Mammography or Tomosynthesis (3D Mammography): For a lump in the breast tissue, diagnostic mammography is usually the first step for patients 40 and older, and may be used for ages 30–39 [12][17]. Mammography looks for masses, architectural distortion (abnormal pulling or tethering of the tissue), or microcalcifications (tiny calcium deposits). Because standard mammogram views might not capture all the tissue high in the armpit, technologists may take extra, targeted views or rely on ultrasound for that area [18][13].
When imaging is complete, the radiologist will assign a BI-RADS category, which helps determine the next step:
- BI-RADS 1 or 2: Negative or benign (non-cancerous).
- BI-RADS 3: Probably benign; a short-interval follow-up (often in 6 months) is usually recommended to monitor for changes [19].
- BI-RADS 4 or 5: Suspicious or highly suspicious; tissue sampling is generally recommended [20].
3. Image-Guided Biopsy
While imaging can sometimes confidently identify a simple cyst or a normal lymph node, a suspicious solid mass (BI-RADS 4 or 5) typically requires a biopsy—where a needle is used to take a small tissue sample for a pathologist to examine under a microscope [20][21].
- The type of biopsy depends on the lump. A core-needle biopsy is generally preferred for a suspicious solid breast mass because it preserves tissue architecture [2]. A fine-needle aspiration (FNA) uses a thinner needle and can be appropriate for evaluating fluid in a cyst or sampling certain lymph nodes [22][2].
- During a core biopsy, you will receive local anesthetic, and a small marker clip is often left in the breast to mark the spot. You may experience temporary bruising or soreness.
Sometimes, imaging might look normal, but the lump remains highly suspicious to the doctor during the clinical exam. This is called clinical-imaging discordance (the exam remains concerning even though images look reassuring) [21]. In these cases, a biopsy or surgical removal is still warranted to ensure nothing is missed [21]. Furthermore, if a biopsy returns a benign result that does not logically explain the suspicious imaging or physical exam, repeat biopsy or surgery is needed [23].
Common questions in this guide
What tests are used to check a lump in the upper-outer breast or armpit?
Does an armpit lump always mean breast cancer?
What does my BI-RADS result mean?
What if my mammogram or ultrasound is normal but I can still feel the lump?
When is a biopsy needed for a breast or armpit lump?
Which symptoms mean I should seek care sooner?
One line in your results can change your plan.
The BI-RADS category from imaging helps determine whether a biopsy is needed. We check your results against the latest research to help you prepare for what’s next.
Related questions
Show more
Get notified when new evidence is published on female breast upper-outer quadrant cancer.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (23)
- 1
ACR Appropriateness Criteria® Palpable Breast Masses.
, Moy L, Heller SL, et al.
Journal of the American College of Radiology : JACR 2017; (14(5S)):S203-S224 doi:10.1016/j.jacr.2017.02.033.
PMID: 28473077 - 2
[Exploring a non-inflammatory clinical breast mass: Clinical practice guidelines].
Legendre G, Guilhen N, Nadeau C, et al.
Journal de gynecologie, obstetrique et biologie de la reproduction 2015; (44(10)):904-12.
PMID: 26541562 - 3
Determining the relative frequency of ultrasound findings in women under 30 years of age with a breast mass.
Roostaee A, Soleimani M, Younesi L, et al.
Journal of family medicine and primary care 2022; (11(9)):5442-5446 doi:10.4103/jfmpc.jfmpc_2171_21.
PMID: 36505614 - 4
Benign Phyllodes Tumor of Axillary Tail USG and Elastography Evaluation with Histopathological Correlation.
Reddy GSN, Phatak SV, Ganta P, Vadlamudi N
Journal of medical ultrasound 2024; (32(1)):86-88 doi:10.4103/jmu.jmu_58_22.
PMID: 38665349 - 5
Sonographic Findings of Accessory Breast Tissue in Axilla and Related Diseases.
Lim HS, Kim SJ, Baek JM, et al.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2017; (36(7)):1469-1478 doi:10.7863/ultra.16.06056.
PMID: 28370098 - 6
Review of axillary lesions, emphasising some distinctive imaging and pathology findings.
Gupta A, Metcalf C, Taylor D
Journal of medical imaging and radiation oncology 2017; (61(5)):571-581 doi:10.1111/1754-9485.12579.
PMID: 28168804 - 7
It's Not Always Gynecomastia: A Case of Diffuse Large B-Cell Lymphoma Presenting as Breast Mass in a Male Patient.
Leon A, Way AR, Sharma S, Letter H
Cureus 2021; (13(1)):e12944 doi:10.7759/cureus.12944.
PMID: 33654621 - 8
Male Breast: Clinical and Imaging Evaluations of Benign and Malignant Entities with Histologic Correlation.
Chau A, Jafarian N, Rosa M
The American journal of medicine 2016; (129(8)):776-91.
PMID: 26844632 - 9
Unusual site, familiar pathology: A case of fibroadenoma in ectopic breast tissue.
Schonour RB, Mowry MH
Radiology case reports 2025; (20(12)):5896-5901 doi:10.1016/j.radcr.2025.08.057.
PMID: 41140559 - 10
Accessory Breast Carcinoma Masquerading as a Sebaceous Cyst in a Breast Cancer Survivor: A Diagnostic Pitfall in Axillary Assessment.
Mok KYN, Lam PW
Cureus 2026; (18(7)):e113541 doi:10.7759/cureus.113541.
PMID: 42666224 - 11
Management of breast complaints and high-risk lesions.
Pleasant V
Best practice & research. Clinical obstetrics & gynaecology 2022; (83()):46-59 doi:10.1016/j.bpobgyn.2022.03.017.
PMID: 35570155 - 12
Evaluation of Palpable Breast Abnormalities.
Dodelzon K, Katzen JT
Journal of breast imaging 2019; (1(3)):253-263 doi:10.1093/jbi/wbz040.
PMID: 38424759 - 13
Do Primary Care Physician Perform Clinical Breast Exams Prior to Ordering a Mammogram?
Larson KE, Cowher MS, O'Rourke C, et al.
The breast journal 2016; (22(2)):189-93 doi:10.1111/tbj.12546.
PMID: 26687763 - 14
A multidisciplinary approach to axillary lymph node staging with ultrasound in the setting of a highly suggestive or suspicious breast mass.
Cubbison A, Wang LC, Friedewald S, et al.
Clinical imaging 2022; (87()):56-60 doi:10.1016/j.clinimag.2022.04.011.
PMID: 35504238 - 15
Imaging in pregnancy-associated breast cancer: a case report.
Untanas A, Grigaitė I, Briedienė R
Acta medica Lituanic 2019; (26(2)):134-139 doi:10.6001/actamedica.v26i2.4034.
PMID: 31632188 - 16
Diagnosis and treatment of advanced HER2-positive breast cancer in young pregnant female: A case report.
Tang T, Liu Y, Yang C, Ma L
Medicine 2020; (99(44)):e22929 doi:10.1097/MD.0000000000022929.
PMID: 33126355 - 17
ACR Appropriateness Criteria Palpable Breast Masses.
Harvey JA, Mahoney MC, Newell MS, et al.
Journal of the American College of Radiology : JACR 2016; (13(11S)):e31-e42 doi:10.1016/j.jacr.2016.09.022.
PMID: 27814822 - 18
A Case Report on Ductal Carcinoma in situ Arising from Axillary Accessory Breast Tissue.
Lee KE, Kang J, Kang WY, Woo OH
Journal of the Korean Society of Radiology 2025; (86(1)):154-159 doi:10.3348/jksr.2024.0029.
PMID: 39958511 - 19
Palpable breast abnormalities in women under age 40.
Lee MV, Shaw HL, Chi T, et al.
The breast journal 2018; (24(5)):798-805 doi:10.1111/tbj.13035.
PMID: 29687544 - 20
Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF): benign breast tumors - short text.
Lavoué V, Fritel X, Antoine M, et al.
European journal of obstetrics, gynecology, and reproductive biology 2016; (200()):16-23.
PMID: 26967341 - 21
Triple assessment breast clinics: The value of clinical core biopsies.
Maha R, Alison J, Michael S, Manvydas V
Irish journal of medical science 2024; (193(2)):565-570 doi:10.1007/s11845-023-03445-z.
PMID: 37550600 - 22
Fine-Needle Aspiration Biopsy of Palpable Breast Masses: Patterns of Clinical Use and Patient Experience.
Ly A, Ono JC, Hughes KS, et al.
Journal of the National Comprehensive Cancer Network : JNCCN 2016; (14(5)):527-36 doi:10.6004/jnccn.2016.0061.
PMID: 27160231 - 23
Correlation of Histopathology and Radiological Findings Among the Diverse Breast Lesions in a Tertiary Care Centre.
Mohan R, Selvakumar A S, S R, et al.
Cureus 2024; (16(1)):e52097 doi:10.7759/cureus.52097.
PMID: 38344545
This page is for informational purposes only and does not constitute medical advice. A clinician should interpret your breast or armpit lump, imaging, and biopsy results and advise you about the next steps.